Article Details

Imara closes $63M Series B funding round for blood disorder drug development

Retrieved on: 2019-03-17 21:52:30

Tags for this article:

Click the tags to see associated articles and topics

Imara closes $63M Series B funding round for blood disorder drug development. View article details on hiswai:

Excerpt

<div>Other participants in the round included RA Capital, Rock Springs Capital and existing investors <b>New Enterprise Associates</b>, Pfizer Venture ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up